Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)
Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –
Integra LifeSciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Integra LifeSciences's pe ratio was 64.7× on Oct 31, 2024, against 22.9× a year earlier. Over the last 5 years it ranged from 18.4× to 168.1×, with a median of 34.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 64.7× | +28.7 |
| 2023 | Dec 29, 2023 | 36.0× | +8.8 |
| 2022 | Dec 30, 2022 | 27.2× | +0.8 |
| 2021 | Dec 31, 2021 | 26.4× | −70.5 |
| 2020 | Dec 31, 2020 | 96.9× | +12.4 |
| 2019 | Dec 31, 2019 | 84.5× | +38.9 |
| 2018 | Dec 31, 2018 | 45.6× | −32.9 |
| 2017 | Dec 29, 2017 | 78.5× | +24.2 |
| 2016 | Dec 30, 2016 | 54.3× | +6.3 |
| 2015 | Oct 30, 2015 | 48.0× | −3.0 |
| 2014 | Dec 31, 2014 | 51.1× | −4.1 |
| 2013 | Oct 31, 2013 | 55.2× | +24.6 |
| 2012 | Dec 31, 2012 | 30.6× | +10.9 |
| 2011 | Dec 30, 2011 | 19.8× | −0.7 |
| 2010 | Dec 31, 2010 | 20.5× | −14.3 |
| 2009 | Dec 31, 2009 | 34.7× | – |
See a number that looks wrong?